SCHEMBL6192497

SCHEMBL6192497

COc1ccc2c(c1)CC(C)CC2=NO

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ MAPT P10636 5/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ APP P05067 1/20 0.46
▸ SNCA P37840 1/20 0.46
▸ METAP1 P53582 3/20 0.45
▸ ACHE P22303 1/20 0.41
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ NFKB1 P19838 2/20 0.40
▸ NFKB2 Q00653 2/20 0.40
▸ RELA Q04206 2/20 0.40
▸ CYP19A1 P11511 1/20 0.39
▸ HTR2C P28335 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ CYP1A1 P04798 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2E1 P05181 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL355824 0.78 HTT (0.57) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL16082212 0.78 HTT (0.57) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL355825 0.78 HTT (0.57) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL1699503 0.76 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2METAP1ACHECYP19A1
SCHEMBL31619577 0.76 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2METAP1ACHECYP19A1
SCHEMBL1809661 0.75 MAPT (0.55) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL1806126 0.75 MAPT (0.55) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL11971460 0.75 MAPT (0.55) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL16233623 0.75 DRD2 (0.56) ACHECYP19A1HTR2CDRD2DRD3
SCHEMBL13799409 0.75 DRD2 (0.56) ACHECYP19A1HTR2CDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1439841-A4 ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF MERCK & CO INC (US) 2005-11-09 — — EP disclosed
EP-1439841-A2 ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF Merck & Co., Inc. (US) 2004-07-28 — — EP disclosed
WO-2003034987-A2 ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF MERCK & CO., INC. (US) 2003-05-01 — — WO disclosed
Send feedback